Is MDA legal in United Arab Emirates?

Also known as: sass, sally

Legal status

Tenamfetamine is placed in Schedule 5 of Decision No. 158 of 2025 at the printed entry «MDA؛ ميثيلين ديوكسي أمفيتامين», which carries the abbreviation and the Arabic methylenedioxy amphetamine description. The dossier's finding on this row is that the substance is controlled by its own entry and is not interchangeable with the N-methylated compound that has an entry of its own in the same schedule, so sharing the substituted amphetamine skeleton is not the reason either is controlled. That is worth stating because a certificate of analysis distinguishing the two is doing legal work rather than merely chemical work. Schedule 5 puts the row in the Articles 10, 41 and 57 branch, with Schedule 10 carrying the quantity bands. The placement was read on 20 September 2026.

Consequences if caught

Schedule 5 is one of the four schedule groups Article 57 names, and this entry is a Schedule 5 entry. The dossier records Article 57 as stating mandatory death for its trafficking or promotion trigger and as stating no quantity for it, and records that the Schedule 10 bands do not gate that route. Because both this compound and the N-methylated one sit in Schedule 5, the identification question that matters chemically does not change the article that applies, but it does still have to be answered correctly before anything is said about the row at all. Article 41 carries the personal use route for this branch, with its tariff unstated in the dossier.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: the Schedule 5 placement at the entry «MDA؛ ميثيلين ديوكسي أمفيتامين», with no medicinal product, research authorisation or prescribing route recorded against it. The medical question is deferred rather than reasoned out of the branch.

Documentation

No documentation route is recorded for this substance. Provenance: the Schedule 5 placement and the entry «MDA؛ ميثيلين ديوكسي أمفيتامين» were read on 20 September 2026, and the capital analysis rests on Article 57 rather than on the Schedule 10 bands. The practical point is that material sold under a name that could describe either this compound or the N-methylated one is not documented by that name, and only an analysis identifies which entry is engaged.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.